Cathie's Ark LogoCathie's Ark
BEGIN TYPING TO SEARCH BY TICKER
Cerus Corp. Logo

ARKG Holdings of Cerus Corporation (CERS) - Updated Daily

Maxinomics.com icon
YouTube Logo
Date
Direction
Shares
Fund Weight
Fund
October 4, 2021
BUY119.000k0.01%ARKG
  • 1
  • 5 / page

Key Statistics

🕵🏼Found In🏷Last Price
ARKKARKG$4.15
⚖️Weighting🧢Market Cap
0.7%$736.30m
🏋🏿‍♂️Weight Rank In ARKG🧮Price to Sales
394.66
🏋️‍♀️Weight Rank Across All Funds🌏Country
38🇺🇸United States
💳ARK Estimated Cost Average🎫ARK Ownership Percent
$3.262.14%
Description
Cerus Corporation is dedicated solely to safeguarding the world's blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. The INTERCEPT red blood cell system is under regulatory review in Europe, and in late-stage clinical development in the US. Also in the US, the INTERCEPT Blood System for Cryoprecipitation is approved for production of Pathogen Reduced Cryoprecipitated Fibrinogen Complex, a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency.
Website
www.cerus.com

Research Notes and Commentary for CERS